Patent · US Active

Pyrazolopyrimidines having activity against the respiratory syncytial virus (RSV)

US11339165B2 · kind B2 · utility

0Cited by

16References

16Claims

0Family size

Assignee

Janssen Sciences Ireland Unlimited Company · IE

Inventors

David Francis Alain Lançois · Louviers, FR
Jérôme Emile Georges Guillemont · Andé, FR
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Dirk André Emmy Roymans · Turnhout, BE
Peter RIGAUX · Overijse, BE
Antoine Benjamin Michaut · Illkirch-Graffenstaden, FR
Guillaume Jean Maurice Mercey · Issy-les-Moulineaux, FR

Key dates

Filing date	Nov 28, 2018
Grant date	May 24, 2022
Priority date	—
Expiry date	Jan 10, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns compounds having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection. Formula (Ia).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.